← Back to Search

Prone Positioning (PP) for Coronavirus (CORONA Trial)

N/A

Waitlist Available

Led By Jason Weatherald, MD

Research Sponsored by University of Calgary

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 90 days

Awards & highlights

No Placebo-Only Group

Summary

This trial will test whether lying face-down can improve outcomes for hospitalized patients with breathing problems due to COVID-19, who are not candidates for mechanical ventilation.

Eligible Conditions

Coronavirus
Low Oxygen Levels
COVID-19
Acute Respiratory Distress Syndrome

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 90 days

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~90 days

This trial's timeline: 3 weeks for screening, Varies for treatment, and 90 days for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Hospital mortality or discharge to hospice

Secondary study objectives

Admission to ICU

Adverse Events and Serious Adverse Events

Change in SpO2

+6 more

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Prone Positioning (PP)Experimental Treatment1 Intervention

The intervention for this study is PP. Patients at participating sites allocated to the intervention arm of the study will be prompted by ward nurses and respiratory therapists to assume and maintain a prone position for varying durations, four times per day.

Group II: Control - usual managementActive Control1 Intervention

The control group will consist of standard medical care with no instructions or prompts to change positioning to staff or patients.

Do I qualify?Apply below to find out